<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">397500041</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180308164530.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">161202s1995    xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1093/imammb/12.1.55</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)oxford-10.1093/imammb/12.1.55</subfield>
  </datafield>
  <datafield tag="100" ind1="1" ind2=" ">
   <subfield code="a">MURRAY</subfield>
   <subfield code="D">J. M.</subfield>
   <subfield code="u">School of Mathematics, University of New South Wales, Sydney, NSW 2052, Australia</subfield>
  </datafield>
  <datafield tag="245" ind1="1" ind2="3">
   <subfield code="a">An example of the effects of drug resistance on the optimal schedule for a single drug in cancer chemotherapy</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[J. M. MURRAY]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">In this paper the authors study the effects of drug resistance on the optimal drug schedule of a single drug in cancer chemotherapy. The optimal schedule is analytically determined when the tumour grows exponentially and the drug has a linear killing action. Drug resistance enters into the model via an effectiveness term that decreases the cell loss as the accumulation of the drug grows. It is found that the optimal schedule is one where the drug is given at its maximum feasible dose from the onset, with some difference at the end of treatment depending on the relative speeds with which resistance develops.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">© Oxford University Press</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Articles</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">cancer chemotherapy</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">drug resistance</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">optimal control</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Mathematical Medicine and Biology</subfield>
   <subfield code="d">Oxford University Press</subfield>
   <subfield code="g">12/1(1995), 55-69</subfield>
   <subfield code="x">1477-8599</subfield>
   <subfield code="q">12:1&lt;55</subfield>
   <subfield code="1">1995</subfield>
   <subfield code="2">12</subfield>
   <subfield code="o">imammb</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1093/imammb/12.1.55</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1093/imammb/12.1.55</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">100</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">MURRAY</subfield>
   <subfield code="D">J. M.</subfield>
   <subfield code="u">School of Mathematics, University of New South Wales, Sydney, NSW 2052, Australia</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Mathematical Medicine and Biology</subfield>
   <subfield code="d">Oxford University Press</subfield>
   <subfield code="g">12/1(1995), 55-69</subfield>
   <subfield code="x">1477-8599</subfield>
   <subfield code="q">12:1&lt;55</subfield>
   <subfield code="1">1995</subfield>
   <subfield code="2">12</subfield>
   <subfield code="o">imammb</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">CC BY-NC-4.0</subfield>
   <subfield code="u">http://creativecommons.org/licenses/by-nc/4.0</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-oxford</subfield>
  </datafield>
 </record>
</collection>
